Top

Supportive Care in Cancer

Published in:

Open Access 01-10-2023 | Review

Taste disturbance in patients with advanced cancer: a scoping review of clinical features and complications

Authors: Marie Hannon, Annelie Shaw, Michael Connolly, Andrew Davies

Published in: Supportive Care in Cancer | Issue 10/2023

Abstract

Purpose

The purpose of this scoping review is to appraise the published literature on taste disturbance in patients with advanced cancer, with the specific objectives being to determine its prevalence, clinical features and complications.

Methods

This scoping review was conducted using the recommended methodological framework. A detailed search of databases (Medline, Embase, CINAHL and PsycInfo) was conducted to identify eligible studies: eligible studies needed to include patients with advanced cancer and needed to include details of clinical features and/or complications of taste disturbance. Standard bibliographic/systematic review software was used to store the records and manage the review process, respectively.

Results

Twenty-five studies were identified from the database searches. The studies identified included eight physical and/or psychological symptom studies, six symptom cluster studies, five oral symptom studies and six taste and/or smell specific studies. Detailed data is presented on the clinical features and complications of taste disturbance and on the symptom clusters involving taste disturbance in this cohort of patients.

Conclusion

This scoping review identified a relatively small number of relevant studies involving a relatively small number of participants. Nevertheless, it confirms that taste disturbance is a common problem in patients with advanced cancer and is associated with significant morbidity because of the primary condition and the associated complications.

Available only for authorised users

Breslin PA, Spector AC (2008) Mammalian taste perception. Curr Biol 18:R148–R155. https://doi.org/10.1016/j.cub.2007.12.017CrossRefPubMed

Boltong A, Keast R, Aranda SK (2011) Talking about taste: how do oncology clinicians discuss and document taste problems? Cancer Forum 35:81–87

Galaniha LT, Nolden AA (2023) Taste loss in cancer patients: clinicians’ perceptions of educational materials and diagnostic tools. Support Care Cancer 31:349. https://doi.org/10.1007/s00520-023-07794-4CrossRefPubMedPubMedCentral

Boltong A, Keast RS, Aranda SK (2011) A matter of taste: making the distinction between taste and flavor is essential for improving management of dysgeusia. Support Care Cancer 19:441–442. https://doi.org/10.1007/s00520-011-1085-0CrossRefPubMed

Boltong A, Keast R (2012) The influence of chemotherapy on taste perception and food hedonics: a systematic review. Cancer Treat Rev 38:152–163. https://doi.org/10.1016/j.ctrv.2011.04.008CrossRefPubMed

Mela DJ (2006) Eating for pleasure or just wanting to eat? Reconsidering sensory hedonic responses as a driver of obesity. Appetite 47:10–17. https://doi.org/10.1016/j.appet.2006.02.006CrossRefPubMed

Epstein JB, Barasch A (2010) Taste disorders in cancer patients: pathogenesis, and approach to assessment and management. Oral Oncol 46:77–81. https://doi.org/10.1016/j.oraloncology.2009.11.008CrossRefPubMed

Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, Elting LS, Spijkervet FK, Brennan MT (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18:1081–1087. https://doi.org/10.1007/s00520-010-09021CrossRefPubMed

Henkin RI, Levy LM, Fordyce A (2013) Taste and smell function in chronic disease: a review of clinical and biochemical evaluations of taste and smell dysfunction in over 5000 patients at The Taste and Smell Clinic in Washington, DC. Am J Otolaryngol 34:477–489. https://doi.org/10.1016/j.amjoto.2013.04.006CrossRefPubMed

10.

Liu G, Zong G, Doty RL, Sun Q (2016) Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: a cross-sectional study. BMJ Open 6:e013246. https://doi.org/10.1136/bmjopen-2016-013246CrossRefPubMedPubMedCentral

11.

Barasch A, Epstein JB (2022) Evaluation of taste disorders. BMJ Best Practice https://bestpractice.bmj.com/topics/en-us/971.

12.

Spotten LE, Corish CA, Lorton CM, Ui Dhuibhir PM, O'Donoghue NC, O’Connor B, Walsh TD (2017) Subjective and objective taste and smell changes in cancer. Ann Oncol 28:969–984. https://doi.org/10.1093/annonc/mdx018CrossRefPubMed

13.

Ui Dhuibhir P, Barrett M, O’Donoghue N, Gillham C, El Beltagi N, Walsh D (2020) Self-reported and objective taste and smell evaluation in treatment-naive solid tumour patients. Support Care Cancer 28:2389–2396. https://doi.org/10.1007/s00520-019-05017-3CrossRefPubMed

14.

Buttiron Webber T, Briata IM, DeCensi A, Cevasco I, Paleari L (2023) Taste and smell disorders in cancer treatment: results from an integrative rapid systematic review. Int J Mol Sci 24. https://doi.org/10.3390/ijms24032538

15.

Gunn L, Gilbert J, Nenclares P, Soliman H, Newbold K, Bhide S, Wong KH, Harrington K, Nutting C (2021) Taste dysfunction following radiotherapy to the head and neck: a systematic review. Radiother Oncol 157:130–140. https://doi.org/10.1016/j.radonc.2021.01.021CrossRefPubMed

16.

Epstein JB, de Andrade ESSM, Epstein GL, Leal JHS, Barasch A, Smutzer G (2019) Taste disorders following cancer treatment: report of a case series. Support Care Cancer 27: 4587-4595. https://doi.org/https://doi.org/10.1007/s00520-019-04758-5

17.

Ripamonti C, Fulfaro F (2010) Taste disturbance. In: Davies AN, Epstein JB (eds) Oral complications of cancer and its management. Oxford University Press, Oxford, pp 225–232CrossRef

18.

Spencer AS, da Silva DD, Capelas ML, Pimentel F, Santos T, Neves PM, Makitie A, Ravasco P (2021) Managing severe dysgeusia and dysosmia in lung cancer patients: a systematic scoping review. Front Oncol 11:774081. https://doi.org/10.3389/fonc.2021.774081CrossRefPubMedPubMedCentral

19.

Pellegrini M, Merlo FD, Agnello E, Monge T, Devecchi A, Casalone V, Montemurro F, Ghigo E, Sapino A, Bo S (2023) Dysgeusia in patients with breast cancer treated with chemotherapy-a narrative review. Nutrients 15. https://doi.org/10.3390/nu15010226

20.

Togni T, L, Mascitti M, Vignigni A, Alia S, Sartini D, Barlattani A, Emanuelli M, Santarelli A (2021) Treatment-related dysgeusia in oral and oropharyngeal cancer: a comprehensive review. Nutrients 13. https://doi.org/10.3390/nu13103325

21.

Deshpande TS, Blanchard P, Wang L, Foote RL, Zhang X, Frank SJ (2018) Radiation-related alterations of taste function in patients with head and neck cancer: a systematic review. Curr Treat Options Oncol 19:72. https://doi.org/10.1007/s11864-018-0580-7CrossRefPubMedPubMedCentral

22.

Twycross RG, Lack SA (1986) Control of alimentary symptoms in far advanced cancer. Churchill Livingstone, Edinburgh

23.

Santini D, Armento G, Giusti R, Ferrara M, Moro C, Fulfaro F, Bossi P, Arena F, Ripamonti CI (2020) Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment. ESMO Open 5:e000933. https://doi.org/10.1136/esmoopen-2020-000933CrossRefPubMedPubMedCentral

24.

Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int. J. Soc. Res. Methodol 8:19–32. https://doi.org/10.1080/1364557032000119616CrossRef

25.

Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P, Godfrey CM, Khalil H (2021) Updated methodological guidance for the conduct of scoping reviews. JBI Evid Implement 19:3–10. https://doi.org/10.11124/JBIES-20-00167CrossRefPubMed

26.

McGowan J, Straus S, Moher D, Langlois EV, O'Brien KK, Horsley T, Aldcroft A, Zarin W, Garitty CM, Hempel S, Lillie E, Tuncalp Ӧ, Tricco AC (2020) Reporting scoping reviews-PRISMA ScR extension. J Clin Epidemiol 123:177–179. https://doi.org/10.1016/j.jclinepi.2020.03.016CrossRefPubMed

27.

National Cancer Institute Dictionary of Cancer Terms (2022) https://www.cancer.gov/publications/dictionaries/cancerterms/def/advanced-cancer.

28.

Aktas A, Walsh D, Hu B (2014) Cancer symptom clusters: an exploratory analysis of eight statistical techniques. J Pain Symptom Manage 48:1254–1266. https://doi.org/10.1016/j.jpainsymman.2014.02.006CrossRefPubMed

29.

Bovio G, Montagna G, Bariani C, Baiardi P (2009) Upper gastrointestinal symptoms in patients with advanced cancer: relationship to nutritional and performance status. Support Care Cancer 17:1317–1324. https://doi.org/10.1007/s00520-009-0590-xCrossRefPubMed

30.

Brisbois TD, de Kock IH, Watanabe SM, Baracos VE, Wismer WV (2011) Characterization of chemosensory alterations in advanced cancer reveals specific chemosensory phenotypes impacting dietary intake and quality of life. J Pain Symptom Manage 41:673–683. https://doi.org/10.1016/j.jpainsymman.2010.06.022CrossRefPubMed

31.

Mahmoud FA, Aktas A, Walsh D, Hullihen B (2011) A pilot study of taste changes among hospice inpatients with advanced cancer. Am J Hosp Palliat Care 28:487–492. https://doi.org/10.1177/1049909111402187CrossRefPubMed

32.

Ozalp GS, Uysal N, Oguz G, Kocak N, Karaca S, Kadiogullari N (2017) Identification of symptom clusters in cancer patients at palliative care clinic. Asia Pac J Oncol Nurs 4:259–264. https://doi.org/10.4103/apjon.apjon_17_17CrossRefPubMedPubMedCentral

33.

Sweeney MP, Bagg J, Baxter WP, Aitchison TC (1998) Oral disease in terminally ill cancer patients with xerostomia. Oral Oncol 34:123–126. https://doi.org/10.1016/s1368-8375(97)00076-6CrossRefPubMed

34.

Tebidze N, Chikhladze NJ, E. Margvelashvili, V. Jincharadze, M. , Kordzaia D (2019) Perception of oral problems in patients with advanced cancer. Georgian Med News:50–56

35.

Alsirafy SA, Abd El-Aal HH, Farag DE, Radwan RH, El-Sherief WA, Fawzy R (2016) High symptom burden among patients with newly diagnosed incurable cancer in a developing country. J Pain Symptom Manage 51:e1–e5. https://doi.org/10.1016/j.jpainsymman.2016.02.003CrossRefPubMed

36.

Alt-Epping B, Nejad RK, Jung K, Gross U, Nauck F (2012) Symptoms of the oral cavity and their association with local microbiological and clinical findings--a prospective survey in palliative care. Support Care Cancer 20:531–537. https://doi.org/10.1007/s00520-011-1114-z

37.

Chaiviboontham SVH, McCorkle S, R. (2011) Symptom clusters in Thais with advanced cancer. Pac Rim Int J Nurs Res 14:265–277

38.

Davies A, Buchanan A, Todd J, Gregory A, Batsari KM (2021) Oral symptoms in patients with advanced cancer: an observational study using a novel oral symptom assessment scale. Support Care Cancer 29:4357–4364. https://doi.org/10.1007/s00520-020-05903-1CrossRefPubMed

39.

Davies AN (2000) An investigation into the relationship between salivary gland hypofunction and oral health problems in patients with advanced cancer. Dissertation,. Kings College London

40.

Davies AN, Kaur K (1998) Taste problems in patients with advanced cancer. Palliative Medicine 12:482–483

41.

Hutton JL, Baracos VE, Wismer WV (2007) Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manage 33:156–165. https://doi.org/10.1016/j.jpainsymman.2006.07.017CrossRefPubMed

42.

Kirkova J, Walsh D, Rybicki L, Davis MP, Aktas A, Tao J, Homsi J (2010) Symptom severity and distress in advanced cancer. Palliat Med 24:330–339. https://doi.org/10.1177/0269216309356380CrossRefPubMed

43.

Kirkova J, Aktas A, Walsh D, Rybicki L, Davis MP (2010) Consistency of symptom clusters in advanced cancer. Am J Hosp Palliat Care 27:342–346. https://doi.org/10.1177/1049909110369869CrossRefPubMed

44.

McGettigan N, Dhuibhir PU, Barrett M, Sui J, Balding L, Higgins S, O’Leary N, Kennedy A, Walsh D (2019) Subjective and objective assessment of taste and smell sensation in advanced cancer. Am J Hosp Palliat Care 36:688–696. https://doi.org/10.1177/1049909119832836CrossRefPubMed

45.

O’Donoghue A, Barrett M, Dhuibhir PU, Kennedy A, O’Leary N, Walsh D (2023) Taste and smell abnormalities in advanced cancer: negative impact on subjective food intake. Nutr Clin Pract 1:1–10. https://doi.org/10.1002/ncp.10943CrossRef

46.

Spichiger E, Muller-Frohlich C, Denhaerynck K, Stoll H, Hantikainen V, Dodd M (2011) Symptom prevalence and changes of symptoms over ten days in hospitalized patients with advanced cancer: a descriptive study. Eur J Oncol Nurs 15:95–102. https://doi.org/10.1016/j.ejon.2010.06.005CrossRefPubMed

47.

Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K (2003) Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage 25:420–429. https://doi.org/10.1016/s0885-3924(03)00074-5CrossRefPubMed

48.

Tsai JS, Wu CH, Chiu TY, Chen CY (2010) Significance of symptom clustering in palliative care of advanced cancer patients. J Pain Symptom Manage 39:655–662. https://doi.org/10.1016/j.jpainsymman.2009.09.005CrossRefPubMed

49.

Van Lancker A, Beeckman D, Van Den Noortgate N, Verhaeghe S, Van Hecke A (2017) Frequency and intensity of symptoms and treatment interventions in hospitalized older palliative cancer patients: a multicentre cross-sectional study. J Adv Nurs 73:1455–1466. https://doi.org/10.1111/jan.13230CrossRefPubMed

50.

Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer 14:831–836. https://doi.org/10.1007/s00520-005-0899-zCrossRefPubMed

51.

Webber K, Davies AN, Leach C, Waghorn M (2021) Symptom prevalence and severity in palliative cancer medicine. BMJ Support Palliat Care 0:1–3. https://doi.org/10.1136/bmjspcare-2020-002357CrossRef

52.

Webber K, Davies AN (2011) Validity of the memorial symptom assessment scale-short form psychological subscales in advanced cancer patients. J Pain Symptom Manage 42:761–767. https://doi.org/10.1016/j.jpainsymman.2011.02.007CrossRefPubMed

53.

Heald A, Pieper CF, Schiffman SS (1998) Taste and smell complaints in HIV-infected patients. AIDS 12:1667–1674. https://doi.org/10.1097/00002030-199813000-00015CrossRefPubMed

54.

Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT (2000) The memorial symptom assessment scale short form (MSAS-SF). Cancer 89:1162–1171. https://doi.org/10.1002/1097-0142CrossRefPubMed

55.

Van Lancker A, Beeckman D, Verhaeghe S, Van Den Noortgate N, Grypdonck M, Van Hecke A (2016) An instrument to collect data on frequency and intensity of symptoms in older palliative cancer patients: a development and validation study. Eur J Oncol Nurs 21:38–47. https://doi.org/10.1016/j.ejon.2015.11.003CrossRefPubMed

56.

Henkin RI, Schechter PJ, Hoye R, Mattern CFT (1971) Idiopathic hypogeusia with dysgeusia, hyposmia, and dysosmia. A new syndrome. JAMA 217:434–440PubMed

57.

Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore J, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, Scher H (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics, and distress. Eur J Cancer 30:1226–1236. https://doi.org/10.1016/0959-8049(94)90182-1CrossRef

58.

Epstein JB, Smutzer G, Doty RL (2016) Understanding the impact of taste changes in oncology care. Support Care Cancer 24:1917–1931. https://doi.org/10.1007/s00520-016-3083-8CrossRefPubMed

59.

Enriquez-Fernandez BE, Martinez-Michel L, Thorlakson J, Wismer WV (2020) Patient-reported taste change assessment questionnaires used in the oncology setting: a narrative review. Eur J Oncol Nurs 47:101775. https://doi.org/10.1016/j.ejon.2020.101775CrossRefPubMed

60.

Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8:175–179. https://doi.org/10.1007/s005200050281CrossRefPubMed

61.

Davies AN, Broadley K, Beighton D (2001) Xerostomia in patients with advanced cancer. J Pain Symptom Manage 22:820–825. https://doi.org/10.1016/s0885-3924(01)00318-9CrossRefPubMed

62.

Dong ST, Butow PN, Costa DS, Lovell MR, Agar M (2014) Symptom clusters in patients with advanced cancer: a systematic review of observational studies. J Pain Symptom Manage 48:411–450. https://doi.org/10.1016/j.jpainsymman.2013.10.027CrossRefPubMed

63.

DeWys WD, Walters K (1975) Abnormalities of taste sensation in cancer patients. Cancer 36:1888–1896. https://doi.org/10.1002/10970142CrossRefPubMed

64.

Rydholm M, Strang P (2002) Physical and psychosocial impact of xerostomia in palliative cancer care: a qualitative interview study. Int J Palliat Nurs 8:318–323. https://doi.org/10.12968/ijpn.2002.8.7.10671CrossRefPubMed

65.

Hopkinson JB (2007) How people with advanced cancer manage changing eating habits. J Adv Nurs 59:454–462. https://doi.org/10.1111/j.1365-2648.2007.04283.xCrossRefPubMed

66.

Zhou T, Yang K, Thapa S, Liu H, Wang B, Yu S (2017) Differences in symptom burden among cancer patients with different stages of cachexia. J Pain Symptom Manage 53:919–926. https://doi.org/10.1016/j.jpainsymman.2016.12.325CrossRefPubMed

67.

Jones JA, Chavarri-Guerra Y, Correa LBC, Dean DR, Epstein JB, Fregnani ER, Lee J, Matsuda Y, Mercadante V, Monsen RE, Rajimakers NJH, Saunders D, Soto-Perez-de-Celis E, Sousa MS, Tonkaboni A, Vissink A, Yeoh KS, Davies AN (2022) MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancer. Support Care Cancer 30:8761–8773. https://doi.org/10.1007/s00520-022-07211-2CrossRefPubMedPubMedCentral

68.

Alderman B, Allan L, Amano K, Bouleuc C, Davis M, Lister-Flynn S, Mukhopadhyay S, Davies A (2022) Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/guidance on the use of clinically assisted nutrition in patients with advanced cancer. Support Care Cancer 30:2983–2992. https://doi.org/10.1007/s00520-021-06613-yCrossRefPubMed

Title: Taste disturbance in patients with advanced cancer: a scoping review of clinical features and complications
Authors: Marie Hannon
Annelie Shaw
Michael Connolly
Andrew Davies
Publication date: 01-10-2023
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 10/2023
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-023-08012-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 10/2023

Symptom clusters among breast cancer patients in relation to chemotherapy cycles: a longitudinal study

Hope and its associated factors in cancer patients undergoing drug therapy: a systematic review

Evaluation of electronic patient–reported outcome assessment in inpatient cancer care: a feasibility study

Exploring the health information-seeking practices of breast cancer patients in a middle-income country with a diverse ethnic population: a cross-sectional investigation

Using simulation to enhance primary care sexual health services for breast cancer survivors: a feasibility study

Qualitative evaluation of the life experiences of spouses of prostate cancer patients receiving androgen deprivation therapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer